Biotech Innocan Pharma Celebrates Dr. Joseph Pergolizzi’s Recognition Among Stanford University’s List of the Top 2% Most-Cited Scientists Worldwide October 10, 2024
Biotech Antag Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for Lead Molecule, AT-7687 October 9, 2024
Biotech Pleasantrees Debuts The Cultivar Collab: Small-Batch Collections of Industry-Leading Genetics October 8, 2024
Biotech Satellite Symposium Addresses The Role of Advanced Multiplex Molecular Testing in Diagnostic Stewardship October 6, 2024
Biotech Antengene to Present Results from Three Programs at the 2024 SITC Annual Meeting October 5, 2024
Biotech Biopharmaceutical Research Company Announces First Dose of BRC-002, a First-in-Class Cannabinoid Therapeutic for Complex Regional Pain Syndrome (CRPS), in Investigator-Initiated Study October 4, 2024
Biotech Resolution Therapeutics Announces £63.5 Million Series B Financing and Chair Appointment October 3, 2024
Biotech AstronauTx appoints Jane Rhodes as Chief Executive Officer and Expands Executive Team October 2, 2024
Biotech Resolution Therapeutics Announces Upcoming Presentations at the American Association for the Study of Liver Disease (AASLD) The Liver Meeting® 2024 October 1, 2024
Search
Biotech
October 10, 2024
October 9, 2024
October 8, 2024
October 7, 2024
October 6, 2024
October 5, 2024
October 4, 2024
October 3, 2024
October 2, 2024
October 1, 2024
